News outlets discuss the third report from the U.K. government’s Antimicrobial Review (AMR) Committee. Financial Times: Big pharma risks public backlash on antibiotics, says Jim O’Neill “Pharmaceuticals companies risk a backlash similar to the one experienced by banks after the financial crisis if they fail to invest more in new…

U.N. News Centre: U.N. agency calls for renewed global commitment to develop effective HIV vaccine “To mark HIV Vaccine Awareness Day, the Joint United Nations Programme on HIV/AIDS, or UNAIDS, has renewed its call for a sustained worldwide commitment to finding an effective HIV vaccine. Steadfast in leaving nobody behind…

Center for Global Health Policy’s “Science Speaks”: Budget cuts threaten HIV vaccine development, say experts Rabita Aziz, policy research coordinator for the Center for Global Health Policy, reports from an HIV Vaccine Awareness Day event that took place on Monday and hosted by AVAC, IAVI, and the Bill & Melinda…

News outlets report on findings from the START trial, which show early treatment following HIV diagnosis provides greater benefits than postponing therapy. CQ Roll Call: Fauci Urges Early Start for HIV Treatment Based on New Study Findings “Results from a global study reinforce a United States policy of urging people…

News outlets report on a study on HPV vaccine dosing published Wednesday in The Lancet Oncology. Agence France-Presse: Single dose of vaccine may prevent cervical cancer “A single vaccine shot, rather than the recommended triple dose, may be enough to protect women against cervical cancer, a study said on Wednesday. If…

IRIN: Stigma leaves Liberia’s Ebola workers high and dry “…The majority of the estimated 20,000 or so workers and volunteers who risked their lives during the year-long fight are unable to find work, largely due to lingering stigma and fears about the virus…” (Collins, 6/11). New York Times: A Chinese…

Wall Street Journal: NIH Expands Testing of Ebola Drugs and Vaccines Into New Countries “…The NIH randomized controlled study of ZMapp has expanded from Liberia into Sierra Leone, where about 40 patients have been enrolled so far, according to H. Clifford Lane, deputy director of the NIH’s National Institute of…

News outlets report on a study showing promising results from an early human challenge trial of an experimental dengue vaccine. CNN: New dengue vaccine shows promise “A new type of dengue vaccine called TV003 seems to protect people against at least one type of the virus, according to a small…

CQ HealthBeat: Zika Supplemental Pressure; House Budget Waits “…House budget planners have developed a fiscal 2017 budget resolution but a vote on the measure has been deferred until next month (listen to CQ podcast on delay details). A separate fiscal 2016 supplemental spending bill seeking funds for a Zika virus…

Nature: Zika and birth defects: what we know and what we don’t “…Researchers are piling up evidence at record speed. But much of the epidemiological data from Brazil is poor, largely because a problem was only suspected months after the virus had spread through large parts of the country, and…